Biotech

Regen BioPharma, Inc. Expands Management Team With the Addition of New CFO Todd Caven

SAN DIEGO, CA: ...

Alethia Biotherapeutics Submits a Clinical Trial Application (CTA) for a Phase I Study with AB-16B5, an Inhibitor of EMT in Patients with Advanced Cancers

MONTREAL, QUEBEC: ...

Microbix Reports Virology Revenue Up 8% in First Quarter

TORONTO, ONTARIO: Company Files Several New LumiSort(TM) Patent Applications ...

Vista Partners Updates Coverage on Soligenix, Inc. (Ticker: SNGX); Price Target $7.00

SAN FRANCISCO, CA: ...

GrowPros Acquires Equity Interest in 60K Sq Ft Advanced Stage MMPR Applicant

OTTAWA, ONTARIO: ...

ProMetic Receives $11.4 Million Purchase Order from Multinational Client

LAVAL, QUEBEC: - Second purchase order related to July 8, 2013 licensing and long-term affinity resin supply agreement - Deliveries starting in June 2015 to be completed in first half of 2016 ...

Threshold Pharmaceuticals Announces Pricing of $30 Million Offering of Common Stock and Warrants

SOUTH SAN FRANCISCO, CA: ...

ImmuCell Announces Financial Results for 2014

PORTLAND, ME: Sales for Full Year Increase 26%; Sales for Fourth Quarter Increase 41%; Investing in Company-Owned Facility to Meet Growing Sales Demand ...

MYOS Corporation Research Selected to Be Presented at International Conference on Molecular and Cellular Biology

CEDAR KNOLLS, NJ: ...

Ceapro Expands License Agreement With University of Alberta for PGX Technology

EDMONTON, ALBERTA: Worldwide rights granted to Ceapro to develop and commercialize PGX Technology in "All Industrial Fields" ...